✦ LIBER ✦

Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8+T cell immunity

✍ Scribed by Adrian Bot; Zhiyong Qiu; Raymond Wong; Mihail Obrocea; Kent A Smith

Book ID: 119905598
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 386 KB
Volume: 8
Category: Article
ISSN: 1479-5876
DOI: 10.1186/1479-5876-8-132

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of Programmed Death-1 (PD-1)

Expression of Programmed Death-1 (PD-1) on CD4+ and CD8+ T cells in Rheumatoid Arthritis

✍ Li, Shufeng; Liao, Wensheng; Chen, Meng; Shan, Shiying; Song, Yuanlin; Zhang, Sh 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 214 KB

Negative regulation by Programmed Death

Negative regulation by Programmed Death Ligand-1 during drug-specific priming of T-cells and the influence of Programmed Death-1 on effector T-cell function

✍ Andrew Gibson,Monday Ogese,Andrew Sullivan… 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 232 KB

The role of intrahepatic CD8+ T cell tra

The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation

✍ Oren Shibolet; Ruslana Alper; Lydia Zolotarov; Shivti Trop; Barbara Thalenfeld; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 381 KB

Up-Regulation of PD-L1, IDO, and Tregs i

Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells

✍ Spranger, S.; Spaapen, R. M.; Zha, Y.; Williams, J.; Meng, Y.; Ha, T. T.; Gajews 📂 Article 📅 2013 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 592 KB

Lower expression levels of the programme

Lower expression levels of the programmed death 1 receptor on CD4+CD25+ T cells and correlation with the PD-1.3A genotype in patients with systemic lupus erythematosus

✍ Helga Kristjansdottir; Kristjan Steinsson; Iva Gunnarsson; Gerdur Gröndal; Krist 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB 👁 2 views

Lessons from IAVI-006, a Phase I clinica

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers

✍ A. Guimarães-Walker; N. Mackie; S. McCormack; T. Hanke; C. Schmidt; J. Gilmour; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 498 KB